Data as of Dec 04
| 0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for Accretive Health Inc have a median target of 10.00, with a high estimate of 16.00 and a low estimate of 7.00. The median estimate represents a +22.85% increase from the last price of 8.14.
The current consensus among 6 polled investment analysts is to Hold stock in Accretive Health Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.